Osteonecrose dos maxilares associada ao uso de bisfosfonatos
Bisphosphonate-related osteonecrosis of the jaws
| dc.creator | Passeri, Luis Augusto | |
| dc.creator | Bértolo, Manoel Barros | |
| dc.creator | Abuabara, Allan | |
| dc.date | 2011-08-01 | |
| dc.date | 2014-07-17T17:45:37Z | |
| dc.date | 2015-11-26T11:46:53Z | |
| dc.date | 2014-07-17T17:45:37Z | |
| dc.date | 2015-11-26T11:46:53Z | |
| dc.date.accessioned | 2018-03-28T20:50:33Z | |
| dc.date.available | 2018-03-28T20:50:33Z | |
| dc.identifier | Revista Brasileira de Reumatologia. Sociedade Brasileira de Reumatologia, v. 51, n. 4, p. 404-407, 2011. | |
| dc.identifier | 0482-5004 | |
| dc.identifier | S0482-50042011000400012 | |
| dc.identifier | 10.1590/S0482-50042011000400012 | |
| dc.identifier | http://dx.doi.org/10.1590/S0482-50042011000400012 | |
| dc.identifier | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042011000400012 | |
| dc.identifier | http://www.repositorio.unicamp.br/jspui/handle/REPOSIP/26428 | |
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/26428 | |
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1236218 | |
| dc.description | Bisphosphonates are potent inhibitors of bone resorption, and are used in the treatment of osteoporosis and other diseases that cause bone mass loss, such as Paget's disease, bone metastases, and multiple myeloma, to prevent pathological fractures. Since 2003, avascular osteonecrosis of the jaw has been associated with the use of bisphosphonates, mainly intravenous. According to the literature, the occurrence of osteonecrosis of the jaw has ranged from 0.8% to 12% of the patients on bisphosphonates, most of them on prolonged use. Physicians and odontologists should be aware of that potential complication in dental treatment. | |
| dc.description | Os bisfosfonatos são potentes inibidores da reabsorção óssea e são utilizados no tratamento da osteoporose e de outras doenças que causam a perda de massa óssea, como doença de Paget, metástases ósseas e mieloma múltiplo, prevenindo fraturas patológicas. Desde 2003, estudos associam osteonecrose avascular dos ossos maxilares a seu uso, principalmente intravenoso. Na literatura, há relatos de ocorrência variando de 0,8% a 12%, dos pacientes, na sua maioria em uso prolongado. Médicos e dentistas devem estar cientes dessa potencial complicação no tratamento odontológico. | |
| dc.description | 404 | |
| dc.description | 407 | |
| dc.language | pt | |
| dc.publisher | Sociedade Brasileira de Reumatologia | |
| dc.relation | Revista Brasileira de Reumatologia | |
| dc.rights | aberto | |
| dc.source | SciELO | |
| dc.subject | Osteonecrose | |
| dc.subject | doenças maxilares | |
| dc.subject | osteoporose | |
| dc.subject | osteonecrosis | |
| dc.subject | maxillary diseases | |
| dc.subject | osteoporosis | |
| dc.title | Osteonecrose dos maxilares associada ao uso de bisfosfonatos | |
| dc.title | Bisphosphonate-related osteonecrosis of the jaws | |
| dc.type | Artículos de revistas |